U.S. Infrastructure Stock News

Visa stock has delivered a 51.9% total return over the past five years. At around US$351 per share, however, the valuation checks highlight some tension between a solid track record and a price that does not appear to be an obvious bargain. The intrinsic value estimate from the Excess Returns model suggests Visa is roughly in line with its assessed fair value, while traditional earnings multiples indicate the stock is trading at a premium. Over five years, Visa has returned 51.9%, which is a...

Recent commentary around Colgate-Palmolive (CL) centers on management’s 2030 plan, as investors weigh how premium product expansion and tighter digital plus in store integration might support the stock’s appeal after several years of organic sales growth. See our latest analysis for Colgate-Palmolive. Colgate-Palmolive’s recent 1-month share price return of 4.9% and year-to-date share price return of 19.4%, with the stock now at $92.76, suggest investors are increasingly pricing in the 2030...

Over the last 7 days, the United States market has risen by 1.6%, contributing to a 21% increase over the past year, with earnings projected to grow by 19% annually. In this environment of robust growth, identifying stocks that are potentially undervalued can offer investors opportunities to capitalize on discrepancies between market price and intrinsic value estimates.

Over the last 7 days, the United States market has risen 1.6%, and in the past year, it has climbed 21%, with earnings forecasted to grow by 19% annually. In light of these positive trends, identifying stocks that combine financial robustness with growth potential is crucial for investors looking to capitalize on current conditions. Penny stocks, though often seen as a relic from earlier trading days, can still offer significant opportunities when supported by strong fundamentals; we'll...

Over the last 7 days, the United States market has risen by 1.6%, contributing to a substantial 21% increase over the past year, with earnings forecasted to grow by 19% annually. In this environment of robust growth, stocks with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the company's operations and future prospects.

Over the last 7 days, the United States market has risen by 1.6% and is up 21% over the past year with earnings forecasted to grow by 19% annually. In this favorable environment, selecting dividend stocks like Autoliv that offer consistent income and potential for growth can enhance your portfolio's stability and returns.

In recent weeks, Madison Investments added Moelis & Company to its Madison Mid Cap Fund, citing an attractive valuation after the stock weakened amid concerns that private credit market conditions could weigh on M&A volumes. The move highlights how some institutional investors view Moelis as a high-quality, underappreciated advisory business positioned to benefit as market conditions and deal activity evolve. We’ll now explore how Madison Investments’ valuation-driven entry into Moelis...

DXP Enterprises was recently added to the Russell 2000 Defensive Index and Russell 2000 Growth-Defensive Index, enhancing its profile among institutional investors. This index inclusion, combined with market focus on an upcoming earnings report that is projected to show higher earnings per share and revenue, is drawing increased attention to DXP’s business outlook. We’ll now examine how DXP’s inclusion in key Russell 2000 defensive indices may influence its existing investment narrative...

In late June 2026, Harley-Davidson, Inc. was reclassified across multiple FTSE Russell indices, moving from the Russell 1000 and Midcap families into the Russell 2000, including value and defensive variants, while also announcing the departure of Chief Legal, Compliance and Corporate Affairs Officer Paul Krause and the appointment of successor Gayle Littleton. This reshuffling alters which index-tracking funds hold Harley-Davidson and may influence how investors view the company’s size...

McKesson (MCK) stock has been in focus after a recent 2.09% decline, as investors weighed softer quarterly results against index additions, expanded partnerships and the company’s continued tilt toward higher margin healthcare segments. See our latest analysis for McKesson. Over the past year, McKesson’s share price return has been mixed. A recent 4.52% one-month gain contrasts with a 13.14% decline over three months and a 6.73% fall year to date. Total shareholder return over 1, 3 and 5...

In recent days, EVERTEC has attracted renewed attention as one of Latin America's leading payment processors, with analysts highlighting its strong cash generation, solid annual revenue growth and earnings expansion outpacing peers, underpinned by its ATH debit network across Latin America and the Caribbean. An important angle for investors is EVERTEC's high return on equity, which points to effective capital allocation and management discipline in scaling its payments infrastructure across...

In recent days, Digital Turbine announced the sale of select AdColony assets to Affle MEA FZ and introduced Launchpad, a unified app distribution platform aimed at simplifying deployments across carriers and device makers. Together, the asset sale and Launchpad rollout signal a sharper focus on core media and distribution capabilities, potentially streamlining Digital Turbine’s technology stack and clarifying how it creates value for app developers and partners. We’ll now examine how...

Recently, ePlus highlighted an independent VistaXM survey showing it achieved a Net Promoter Score of 74, well above typical technology industry averages, alongside being named Everpure’s Services Partner of the Year for its Storage-as-a-Service offering. Together, these strong customer satisfaction metrics and partner recognition underscore how ePlus’s focus on customer experience and innovative service models is resonating with its client base. We’ll now examine how this exceptionally high...

Valero Energy (VLO) moved firmly into the large cap arena after being added to several Russell Top 200 and growth benchmarks, while exiting certain mid cap indexes on June 27, 2026. See our latest analysis for Valero Energy. The index reshuffle comes on the back of strong trading interest in Valero Energy, with a 1-day share price return of 3.46% and a 7-day share price return of 11.14%, while the 1-year total shareholder return of 94.52% and 5-year total shareholder return of 339.56%...

Recent coverage has highlighted that Strategic Education’s earnings outlook has improved and that analysts currently view the company as offering relatively attractive value compared with a close peer in the schools sector. This shift in analyst sentiment comes despite earlier concerns about flat domestic student numbers, pressure on per‑share profitability, and expectations for softer cash flow margins. We’ll now examine how this improving analyst sentiment, despite enrollment and...

Artificial intelligence is moving from buzzword to budget line item, and Microsoft’s new US$2.5b Frontier Co unit shows how quickly that shift can affect listed stocks. With 6,000 Microsoft employees now assigned to hands on AI implementation, investors are rethinking which companies could gain from faster adoption and which might face tougher competition or higher expectations. This article looks at 3 stocks from the AI Adoption Leaders screener that are directly exposed to this news and...

In June 2026, NeoGenomics, Inc. announced it had appointed Carolyn Starrett, former Flatiron Health CEO and experienced healthcare data and AI leader, to its Board of Directors. Her background in applying AI and real-world data to cancer care and drug development could meaningfully influence how NeoGenomics develops and commercializes its oncology testing and digital solutions. We’ll now examine how Starrett’s AI and data-driven oncology expertise may influence NeoGenomics’ existing...

Aramark (ARMK) has drawn fresh attention after being added to the Russell 1000 Defensive and Russell 1000 Value Defensive indices, a move that reflects institutional interest in the stock. See our latest analysis for Aramark. Those index additions come after a strong run in Aramark’s share price, with a 90 day share price return of 31.84% and year to date share price return of 53.36%, alongside a 5 year total shareholder return of 129.43%. This suggests momentum has been firm over both short...

BeOne Medicines recently reported positive topline Phase 3 MANGROVE results showing its BTK inhibitor BRUKINSA plus rituximab improved progression-free survival over bendamustine plus rituximab in previously untreated mantle cell lymphoma, using a chemotherapy-free, rituximab maintenance-free regimen. This is the first global Phase 3 trial to test a fully chemotherapy-free BTK inhibitor regimen as initial treatment in mantle cell lymphoma, potentially sparing patients around two years of...

On 27 June 2026, Graham Corporation (NYSE:GHM) was added to both the Russell 2000 Growth-Defensive Index and the Russell 2000 Defensive Index, increasing its prominence among small-cap industrial names. This dual index inclusion comes as Graham reports strong fundamentals and record backlog tied to mission-critical heat-transfer and data center cooling equipment, potentially broadening its institutional investor base. Next, we’ll examine how this index inclusion, alongside record backlog in...

Some PACS Group, Inc. ( NYSE:PACS ) shareholders may be a little concerned to see that the Chief Accounting Officer...

Some Immunovant, Inc. ( NASDAQ:IMVT ) shareholders may be a little concerned to see that the Chief Technology Officer...

In recent days, Range Resources, a US natural gas producer, saw investor attention increase after U.S. natural gas futures rose on forecasts for a heatwave, strong demand, and higher European gas prices supported by solid LNG export activity. This shift in the underlying commodity backdrop is important for Range because natural gas pricing directly feeds into its revenues and cash generation. We’ll now examine how stronger natural gas futures linked to heat-driven demand and LNG exports...

In late June 2026, Spyre Therapeutics filed a US$500 million at-the-market follow-on equity offering and an omnibus shelf registration covering common stock, preferred stock, debt, warrants, and units. Around the same time, the company was removed from several Russell Value indexes, a shift that can affect index-linked institutional ownership and trading flows. We’ll explore how Spyre Therapeutics’ large at-the-market equity program shapes its investment narrative and the potential...